Press Releases

Second Sight to Discuss Fourth Quarter and Year-End 2014 Financial Results on March 11, 2015 Conference Call

SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2014 fourth quarter and year-end financial results on Wednesday, March 11, 2015, after the close of the U.S. financial markets.

Dr. Robert Greenberg, President and Chief Executive Officer, and Tom Miller, Chief Financial Officer, will host a conference call to discuss the results as follows:

A replay of the conference call will be available for two weeks after the call's completion by dialing (800) 633-8284 (U.S.) or (402) 977-9140 (International). The conference ID for the replay is 21763065. The archived webcast will be available for 30 days via the aforementioned URL.

About Second Sight

Second Sight Medical Products, Inc. was founded in 1998 to create a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations such as retinitis pigmentosa. Second Sight's mission is to develop, manufacture, and market innovative implantable visual prosthetics to enable blind individuals to achieve greater independence. The company’s Argus II retinal prosthesis is approved in the U.S. and Europe. Second Sight is developing the Orion^TM cortical prosthesis to restore some vision to individuals who are blind due to causes other than preventable or treatable conditions. The company’s headquarters are in Sylmar, California, and its European Headquarters are in Lausanne, Switzerland. For more information, please visit www.secondsight.com.

Safe Harbor

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended that are intended to be covered by the “safe harbor” created by those sections. All statements in this release that are not based on historical fact are “forward looking statements”. While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections contained within our final prospectus filed with the United States Securities and Exchange Commission on November 20, 2014. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Investor Relations Contacts:
Retail Investors:
MZ North America
Matt Hayden, 949-259-4896
Chairman
matt.hayden@mzgroup.us
or
Institutional Investors:
In-Site Communications, Inc.
Lisa Wilson, 212-452-2793
President
lwilson@insitecony.com

Source: Second Sight Medical Products, Inc.

Released February 27, 2015